Morgan Stanley’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Morgan Stanley's ADRX Position: Q3 2026 in Review
Morgan Stanley opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 22,544 shares worth $450K. The stake represents ﹤0.01% of the portfolio and ranks #5655 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Morgan Stanley held 22,544 shares of ADARx Pharmaceuticals worth $450K as of Q3 2026.
- ADARx Pharmaceuticals was a new Morgan Stanley position in Q3 2026.
- ADARx Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #5655 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.